Learn More about Lumida ETF
Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes Biotech

Revolutionary Al Model Foresees Dementia Years Ahead

by Team Lumida
June 11, 2024
in Biotech, Health and Longevity
Reading Time: 3 mins read
A A
0
an abstract image of a sphere with dots and lines

Photo by Growtika on Unsplash

Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

  1. New AI model predicts dementia up to 9 years early with 82% accuracy.
  2. Early detection could allow for timely interventions, potentially preventing dementia progression.
  3. Researchers emphasize the need for further validation across diverse populations.

What Happened?

Researchers at Queen Mary University of London developed a new machine learning model that predicts dementia with over 80% accuracy up to nine years before diagnosis. Analyzing 1,111 fMRI scans, the model identifies changes in the brain’s default mode network (DMN), particularly when a person is at rest.

The study, published in Nature Mental Health, included 81 individuals who later developed dementia and 1,030 matched controls. The model accurately predicted dementia within a two-year window before diagnosis.

Why It Matters?

This breakthrough offers a significant advancement in early dementia detection. Early diagnosis could lead to timely interventions, potentially delaying or preventing the onset of dementia.

Dr. Claire Sexton of the Alzheimer’s Association emphasized that Alzheimer’s is linked to decreased functional connectivity within the DMN, aligning with these findings. Early detection is crucial as it provides a chance for interventions before significant cognitive decline occurs.

What’s Next?

Researchers aim to validate the model across more diverse populations and different types of dementia, including frontotemporal and Lewy body dementias. Current limitations include the study’s predominantly white, healthier-than-average cohort.

Neurologists like Clifford Segil stress the need for consistent reproducibility of fMRI results. While no neuroprotective medications are available yet, early detection models like this one could guide future clinical trials, ensuring the right candidates receive new treatments as they emerge.

Source: Medical News Today
Tags: Alzheimer'sDementiafMRIMedical AI
Previous Post

Now Economists Predict Just One Rate Cut This Year

Next Post

Commercial Real Estate: Are Office Spaces the Next Big Financial Risk?

Recommended For You

Sleep Regularity Is the Longevity Hack

by Team Lumida
46 minutes ago
woman sleeping on bed under blankets

Key Takeaways: Powered by lumidawealth.com Sleep regularity often matters more than total sleep duration for long-term health outcomes. Irregular sleep schedules are linked to higher risks of metabolic disease,...

Read more

Morning Sunlight: The Low-Effort Longevity Habit That Resets Your Biology

by Team Lumida
3 days ago
sun setting over the mountains

Key Takeaways: Powered by lumidawealth.com 5–15 minutes of morning sunlight exposure helps anchor your circadian clock and improve nighttime sleep. Better circadian alignment is linked to improved metabolism, hormone...

Read more

Protein Timing: The Longevity Hack You Didn’t Know You Needed

by Team Lumida
5 days ago
a container of protein powder next to a spoon

Key Takeaways: Powered by lumidawealth.com Protein intake, especially when spread throughout the day, supports muscle maintenance and longevity. Consuming protein-rich meals in the morning and after workouts maximizes muscle...

Read more

Alzheimer’s Diagnosis Is Fracturing—And Patients Are Caught in the Middle

by Team Lumida
6 days ago
doctor holding red stethoscope

Key takeaways Powered by lumidawealth.com Competing diagnostic standards are leading to contradictory Alzheimer’s diagnoses for the same patient. One camp defines Alzheimer’s biologically by amyloid presence, while another requires...

Read more

AI Is Moving From “Wellness Hype” to Healthcare Infrastructure

by Team Lumida
7 days ago
man running on road near grass field

Key takeaways Powered by lumidawealth.com AI is compressing the cost and time of diagnosis, monitoring, and clinical decision support—pushing healthcare toward earlier intervention and prevention. The biggest near-term value...

Read more

Diet Is the Biggest Longevity Lever Most People Underuse

by Team Lumida
2 weeks ago
poached egg with vegetables and tomatoes on blue plate

Key takeaways The NHS “Eatwell” approach emphasizes variety + proportions across 5 food groups, plus hydration, to support healthy weight and overall health. Most people (UK context) are...

Read more

Longevity Becomes the Next Mega-Market as Healthcare Shifts From Treating Disease to Extending Healthspan

by Team Lumida
2 weeks ago
diagram

Key takeaways Longevity is shifting healthcare from reactive treatment to proactive health optimization, expanding lifetime spending per person. Breakthroughs in metabolic drugs, early diagnostics, AI-driven prevention, and precision...

Read more

Ozempic Turns Weight Loss Into a New “Infrastructure” Market for Healthcare—and Investors

by Team Lumida
2 weeks ago
Ozempic Turns Weight Loss Into a New “Infrastructure” Market for Healthcare—and Investors

Key takeaways What it is: Ozempic is a once-weekly GLP-1 medicine approved for type 2 diabetes and to reduce major cardiovascular risk in certain adults with type 2...

Read more

Muscle Is the Longevity Hack

by Team Lumida
2 weeks ago
topless man with black background

Key takeaways Powered by lumidawealth.com Higher muscle mass is linked to lower mortality, better blood sugar control, and reduced risk of falls and frailty. Muscle acts as a metabolic...

Read more

Sleep Is the Most Underrated Longevity Investment

by Team Lumida
2 weeks ago
Sleep Paralysis Explained: The Science Behind Your Nightmares

Key takeaways Powered by lumidawealth.com Poor sleep is linked to higher risk of heart disease, diabetes, obesity, depression, and early mortality. Consistent sleep timing matters as much as total...

Read more
Next Post
tall trees in front of high-rise buildings

Commercial Real Estate: Are Office Spaces the Next Big Financial Risk?

a close up of the front grill of a car

General Motors Cuts EV Output, Focuses on Shareholders with Massive Buyback

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Can Kevin Plank Revive Under Armour? Major Restructuring Announced

Can Kevin Plank Revive Under Armour? Major Restructuring Announced

May 30, 2024
Senate Passes Genius Act, Paving the Way for Stablecoin Regulation in the U.S.

Senate Passes Genius Act, Paving the Way for Stablecoin Regulation in the U.S.

June 18, 2025
a low angle view of a building

Tencent Q1 2024: Revenue Up, Profit Soars, Shares Buyback in Focus

May 17, 2024

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Latest
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips AI demand Amazon Apple Artificial Intelligence Banking Bitcoin China Commercial Real Estate CPI Crypto Donald Trump EARNINGS ELON MUSK ETF Ethereum Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Nvidia OpenAI private equity S&P 500 SEC Semiconductor stock market Tech Stocks tesla Trump Wells Fargo Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018